Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iberogast in functional dyspepsia with concomitant reflux symptoms
2008-002305-40Phase 2Completed
- Sponsor
- Steigerwald Arzneimittelwerk
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in functional dyspepsia (FD) comparing Iberogast with Placebo (2 arms). Primary endpoint: AUC of patients' assessment of gastrointestinal symptoms. Started Sep 2008; status: completed.
02
Drugs
Iberogast
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2008-002305-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002305-40.